[HTML][HTML] The therapeutic potential of triptolide and celastrol in neurological diseases
Y Cui, X Jiang, J Feng - Frontiers in Pharmacology, 2022 - frontiersin.org
Neurological diseases are complex diseases affecting the brain and spinal cord, with
numerous etiologies and pathogenesis not yet fully elucidated. Tripterygium wilfordii Hook …
numerous etiologies and pathogenesis not yet fully elucidated. Tripterygium wilfordii Hook …
[HTML][HTML] Plant-Based Antioxidants for Prevention and Treatment of Neurodegenerative Diseases: Phytotherapeutic Potential of Laurus nobilis, Aronia melanocarpa …
With the progress of medicine, especially in the last century, life expectancy increased
considerably. As a result, age-related diseases also increased, especially malignancies and …
considerably. As a result, age-related diseases also increased, especially malignancies and …
Celastrol inhibits oligodendrocyte and neuron ferroptosis to promote spinal cord injury recovery
W Shen, C Li, Q Liu, J Cai, Z Wang, Y Pang, G Ning… - Phytomedicine, 2024 - Elsevier
Background Spinal cord injury (SCI) is a traumatic injury to the central nervous system and
can cause lipid peroxidation in the spinal cord. Ferroptosis, an iron-dependent programmed …
can cause lipid peroxidation in the spinal cord. Ferroptosis, an iron-dependent programmed …
[HTML][HTML] The discovery of the new mechanism: celastrol improves spinal cord injury by increasing cAMP through VIP-ADCYAP1R1-GNAS pathway
C Li, W Shen, Z Xu, C Li, Q Liu, Y Pang, J Li… - Biomedicine & …, 2023 - Elsevier
Spinal cord injury (SCI) is a debilitating condition that results in significant impairment of
motor function and sensation. Despite the ongoing efforts to develop effective treatments …
motor function and sensation. Despite the ongoing efforts to develop effective treatments …
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer
X Zeng, X Zhu, Q Tian, X Tan, N Sun, M Yan, J Zhao… - Drug Delivery, 2022 - Taylor & Francis
Celastrol is a promising antitumor drug candidate, but the poor water solubility and
cytotoxicity limit its clinical application. Herein, we synthesized a Celastrol (Cel)-chitosan …
cytotoxicity limit its clinical application. Herein, we synthesized a Celastrol (Cel)-chitosan …
[HTML][HTML] Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease
N Kumari, S Anand, K Shah, NS Chauhan, NK Sethiya… - Molecules, 2023 - mdpi.com
Neurological ailments, including stroke, Alzheimer's disease (AD), epilepsy, Parkinson's
disease (PD), and other related diseases, have affected around 1 billion people globally to …
disease (PD), and other related diseases, have affected around 1 billion people globally to …
[HTML][HTML] Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity
Y Sun, C Wang, X Li, J Lu, M Wang - Frontiers in Pharmacology, 2024 - frontiersin.org
Celastrol is a quinone methyl triterpenoid monomeric ingredient extracted from the root of
Tripterygium wilfordii. Celastrol shows potential pharmacological activities in various …
Tripterygium wilfordii. Celastrol shows potential pharmacological activities in various …
Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat …
L Guo, B Qu, C Song, S Zhu, N Gong, J Sun - Journal of Affective Disorders, 2022 - Elsevier
Background Parkinson's disease (PD) is a neurological disorder. Recently, celastrol (Cel)
has been reported to have neuroprotective properties. We investigated the protective effects …
has been reported to have neuroprotective properties. We investigated the protective effects …
Tripartite motif protein family in central nervous system diseases
M Pan, X Li, G Xu, X Tian, Y Li, W Fang - Cellular and Molecular …, 2023 - Springer
Tripartite motif (TRIM) protein superfamily is a group of E3 ubiquitin ligases characterized by
the conserved RING domain, the B-box domain, and the coiled-coil domain (RBCC). It is …
the conserved RING domain, the B-box domain, and the coiled-coil domain (RBCC). It is …
[HTML][HTML] Tight junction protein 1 suppresses kidney renal clear cell carcinoma cells proliferation by inducing autophagy
M Li, DS Zhou, XR Shao, SH Chan… - … Journal of Medical …, 2023 - ncbi.nlm.nih.gov
TJP1, an adaptor protein of the adhesive barrier, has been found to exhibit distinct
oncogenic or tumor suppressor functions in a cell-type dependent manner. However, the …
oncogenic or tumor suppressor functions in a cell-type dependent manner. However, the …